NAGE
Niagen Bioscience
NAGE
NAGE
54 hedge funds and large institutions have $16.4M invested in Niagen Bioscience in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $17.7M → $16.4M (-$1.3M)
59% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 17
Holders
54
Holding in Top 10
–
Calls
$98K
Puts
$19K
Top Buyers
| 1 | +$203K | |
| 2 | +$136K | |
| 3 | +$79.6K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$66.6K |
| 5 |
Squarepoint
New York
|
+$28K |
Top Sellers
| 1 | -$173K | |
| 2 | -$73.5K | |
| 3 | -$59.2K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$45K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$37K |